Table 4.
Univariate analysis of cognitive function
Variable | Cognitive dysfunction group (n = 41) | Non-disorder group (n = 73) | x2/t value | P value |
---|---|---|---|---|
Age | 8.305 | 0.004 | ||
≥ 60 years (n = 63) | 30 | 33 | ||
< 60 years (n = 51) | 11 | 40 | ||
Sex | 2.638 | 0.104 | ||
Male (n = 67) | 20 | 47 | ||
Female (n = 47) | 21 | 26 | ||
BMI | 0.588 | 0.443 | ||
≥ 25 kg/m2 (n = 42) | 17 | 25 | ||
< 25 kg/m2 (n = 72) | 24 | 48 | ||
Time from onset to admission | 4.494 | 0.034 | ||
≥ 6 h (n = 49) | 23 | 26 | ||
< 6 h (n = 65) | 18 | 47 | ||
Medical history | ||||
Diabetes (n = 51) | 27 | 24 | 11.554 | 0.001 |
Hyperlipidemia (n = 38) | 23 | 15 | 14.932 | 0.001 |
Lesion at critical sites | 11.012 | 0.001 | ||
Critical site (n = 45) | 27 | 18 | ||
Non-critical site (n = 69) | 23 | 55 | ||
NIHSS score before treatment | 23.58±3.77 | 24.97±3.47 | 1.937 | 0.055 |
MRS score before treatment | 3.97±1.04 | 3.97±0.93 | 0.015 | 0.987 |
Note: Body Mass Index (BMI), National Institutes of Health Stroke Scale (NIHSS) score, modified Rankin Scale (mRS) score, frontal lobe, temporal lobe, base, thalamus as critical sites, parietal lobe, occipital lobe, brainstem, cerebellum as non-critical sites.